# Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy

> **NCT00500552** · PHASE2 · COMPLETED · sponsor: **University Hospital Birmingham** · enrollment: 44 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Perhexiline/Placebo

## Key facts

- **NCT ID:** NCT00500552
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2010-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500552, "Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00500552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*